Prognostic effect of factors involved in revised Tokuhashi score system for patients with spinal metastases: a systematic review and Meta-analysis
Background Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients’ quality of life. The prediction of survival plays a k...
Saved in:
| Published in | BMC cancer Vol. 18; no. 1; pp. 1248 - 15 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
13.12.2018
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2407 1471-2407 |
| DOI | 10.1186/s12885-018-5139-2 |
Cover
| Abstract | Background
Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients’ quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS).
Methods
Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants’ characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate.
Results
A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10–40 VS. 50–70 and single VS. multiple spinal metastases.
Conclusion
All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What’s more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10–40 VS. 50–70 and single VS. multiple involved vertebrae. |
|---|---|
| AbstractList | Cancer patients' survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients' quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS). Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants' characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate. A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10-40 VS. 50-70 and single VS. multiple spinal metastases. All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What's more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10-40 VS. 50-70 and single VS. multiple involved vertebrae. Background Cancer patients' survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients' quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS). Methods Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants' characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate. Results A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10-40 VS. 50-70 and single VS. multiple spinal metastases. Conclusion All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What's more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10-40 VS. 50-70 and single VS. multiple involved vertebrae. Keywords: Spinal metastasis, Prognostic factor, Overall survival, Revised Tokuhashi score Background Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients’ quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS). Methods Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants’ characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate. Results A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10–40 VS. 50–70 and single VS. multiple spinal metastases. Conclusion All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What’s more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10–40 VS. 50–70 and single VS. multiple involved vertebrae. Cancer patients' survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients' quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS). Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants' characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate. A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10-40 VS. 50-70 and single VS. multiple spinal metastases. All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What's more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10-40 VS. 50-70 and single VS. multiple involved vertebrae. Abstract Background Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients’ quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS). Methods Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants’ characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate. Results A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10–40 VS. 50–70 and single VS. multiple spinal metastases. Conclusion All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What’s more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10–40 VS. 50–70 and single VS. multiple involved vertebrae. Cancer patients' survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients' quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS).BACKGROUNDCancer patients' survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients' quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS).Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants' characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate.METHODSTwo investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants' characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate.A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10-40 VS. 50-70 and single VS. multiple spinal metastases.RESULTSA total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10-40 VS. 50-70 and single VS. multiple spinal metastases.All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What's more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10-40 VS. 50-70 and single VS. multiple involved vertebrae.CONCLUSIONAll factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What's more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10-40 VS. 50-70 and single VS. multiple involved vertebrae. Background Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients’ quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS). Methods Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants’ characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate. Results A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10–40 VS. 50–70 and single VS. multiple spinal metastases. Conclusion All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What’s more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10–40 VS. 50–70 and single VS. multiple involved vertebrae. |
| ArticleNumber | 1248 |
| Audience | Academic |
| Author | Liu, Yong-heng Yang, Xiong-gang Hua, Kun-chi Lun, Deng-xing Yang, Li Hu, Yong-cheng Zhang, Hao Xu, Ming-you Feng, Jiang-tao Zhang, Hao-ran Wang, Feng |
| Author_xml | – sequence: 1 givenname: Xiong-gang surname: Yang fullname: Yang, Xiong-gang organization: Department of Bone Tumor of Tianjin Hospital – sequence: 2 givenname: Deng-xing surname: Lun fullname: Lun, Deng-xing organization: Weifang People’s Hospital – sequence: 3 givenname: Yong-cheng orcidid: 0000-0002-9846-6735 surname: Hu fullname: Hu, Yong-cheng email: yongchenghu@126.com organization: Department of Bone Tumor of Tianjin Hospital – sequence: 4 givenname: Yong-heng surname: Liu fullname: Liu, Yong-heng organization: Tianjin Medical university – sequence: 5 givenname: Feng surname: Wang fullname: Wang, Feng organization: Tianjin Medical university – sequence: 6 givenname: Jiang-tao surname: Feng fullname: Feng, Jiang-tao organization: Tianjin Medical university – sequence: 7 givenname: Kun-chi surname: Hua fullname: Hua, Kun-chi organization: Tianjin Medical university – sequence: 8 givenname: Li surname: Yang fullname: Yang, Li organization: Tianjin Medical university – sequence: 9 givenname: Hao surname: Zhang fullname: Zhang, Hao organization: Tianjin Medical university – sequence: 10 givenname: Ming-you surname: Xu fullname: Xu, Ming-you organization: Tianjin Medical university – sequence: 11 givenname: Hao-ran surname: Zhang fullname: Zhang, Hao-ran organization: Tianjin Medical university |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30545326$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9k29v0zAQxiM0xLbCB-ANsoSE4EVG7MSJywukaeJPpSEQ7L3lOufWJY07n9Oxr8En5rpu0E5AEiUn5_c89p3ujrODPvSQZU95ccK5ql8jF0rJvOAql7wc5-JBdsSrhueiKpqDnfgwO0ZcFAVvVKEeZYdlIStZivoo-_klhlkfMHnLwDmwiQXHnLEpRGS-X4duDS0FLMLaI4UX4fswNzj3DG2IwPAaEyyZC5GtTPLQJ2RXPs0ZrnxvOraEZJAewDfM3NJms93GEK6Y6Vv2iZjcEH2NHh9nD53pEJ7cfkfZxft3F2cf8_PPHyZnp-e5rWuV8qktjWiVsVxMnRSVlap2omoryaWiVAy0laXcx65SqmhcC9OSCxi3xjZNbctRNtnatsEs9Cr6pYnXOhivbxZCnGkT6ZwdaJhCw6EE0ai2MlT0litQqp6CsqKka5S93XqthukSWktFiKbbM93_0_u5noW1rsW4lEqSwctbgxguB8Cklx4tdJ3pIQyoBZdN3TSlqgl9fg9dhCFS7W4oVQk1ljvUzFACvneB9rUbU30q63FBHUCvUXbyF4ruFpbeUrM5T-t7gld7AmIS_EgzMyDqybev--yLHXYOpktzDN2QfOhxH3y2W73fZbvrUgKaLWBjQIzgtPXJbHzouL7TvNCbedDbedA0D3ozD1qQkt9T3pn_TyO2GiS2n0H8U-B_i34BOA8dYw |
| CitedBy_id | crossref_primary_10_56929_jseaortho_v46i2_150 crossref_primary_10_1016_j_wneu_2023_06_082 crossref_primary_10_1016_j_neucir_2019_08_005 crossref_primary_10_1038_s41394_021_00428_z crossref_primary_10_1080_01616412_2020_1866244 crossref_primary_10_1007_s00520_019_05015_5 crossref_primary_10_1016_j_neucie_2019_08_001 crossref_primary_10_1016_j_asjsur_2023_08_179 crossref_primary_10_1136_bmjopen_2022_069908 |
| Cites_doi | 10.1002/cam4.823 10.2106/JBJS.N.01124 10.1097/00007632-200102010-00016 10.1007/s00586-008-0763-1 10.1097/BRS.0000000000001538 10.1002/cncr.23002 10.1136/bmj.327.7414.557 10.1097/00007632-199011010-00005 10.1056/NEJMoa061884 10.3171/2010.6.SPINE10167 10.3171/2016.5.FOCUS16145 10.1097/01.brs.0000222146.91398.c9 10.1200/JCO.2005.05.0542 10.1016/j.spinee.2015.11.005 10.1097/BRS.0b013e3182983bf8 10.1016/j.ijrobp.2005.06.036 10.1097/BRS.0b013e318074d6c7 10.1097/01.brs.0000180401.06919.a5 10.1136/bmj.315.7109.629 10.1093/neuonc/not318 10.1007/s00586-012-2649-5 10.3340/jkns.2012.51.3.127 10.1016/j.spinee.2014.04.013 10.1002/1097-0142(19951015)76:8<1453::AID-CNCR2820760824>3.0.CO;2-T 10.1016/j.spinee.2012.10.015 10.1007/s00586-015-4290-6 10.1158/1078-0432.CCR-09-0520 10.1097/BRS.0b013e3181e56ec1 10.3760/cma.j.issn.0366-6999.20141625 10.1097/01.PHM.0000083662.85497.1F 10.3171/2009.1.SPINE08509 10.1097/00042737-200111000-00013 10.1056/NEJM199208273270907 10.1097/00007632-199710010-00020 10.1016/S0140-6736(05)66954-1 10.1245/s10434-006-9000-5 10.1186/s13018-015-0291-8 10.1227/NEU.0b013e318207780c 10.1097/BRS.0b013e318207a222 10.1590/0004-282X20150003 10.1007/s00066-012-0086-3 10.1002/cncr.27849 10.3109/17453674.2011.590761 10.1016/j.jocn.2011.02.020 10.3340/jkns.2011.50.3.216 10.1007/s00586-012-2232-0 10.1016/j.clon.2015.01.002 10.1016/j.ijrobp.2010.11.056 10.1186/s12957-016-0961-y 10.1007/s00066-012-0106-3 10.1016/j.clineuro.2014.04.025 10.1016/S0360-3016(99)00333-8 10.5009/gnl14009 10.1016/S0167-8140(97)00112-6 10.1016/j.jotr.2013.12.004 10.1007/s00066-011-0058-z 10.1007/s10585-013-9608-3 10.1111/j.0006-341X.2000.00455.x 10.1097/BRS.0b013e3181e574f5 10.1007/s00432-010-0946-0 10.3109/17453679508995508 10.3340/jkns.2011.50.5.434 10.1002/cncr.20756 10.1016/j.spinee.2014.06.001 10.1186/s12885-015-1852-2 10.1227/NEU.0000000000000070 10.3171/2013.9.SPINE13158 10.1007/s00586-007-0380-4 10.1007/s00066-013-0473-4 10.1007/s00586-012-2480-z 10.3171/foc.2001.11.6.11 10.1097/BRS.0b013e31826011bc 10.1007/s00586-016-4921-6 10.3171/2015.1.SPINE14431 10.1002/cncr.23888 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2018 COPYRIGHT 2018 BioMed Central Ltd. Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s). 2018 – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM ISR 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12885-018-5139-2 |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed Gale In Context: Science ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2407 |
| EndPage | 15 |
| ExternalDocumentID | oai_doaj_org_article_ebe71e3e278d4a128d18e886be8c2333 PMC6293585 A569030590 30545326 10_1186_s12885_018_5139_2 |
| Genre | Journal Article |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW INH INR ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION NPM PMFND 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c668t-bc3a2d8ac12bf524c586f24d45158effaed4c4079f48807fdeb312e9dac776c3 |
| IEDL.DBID | M48 |
| ISSN | 1471-2407 |
| IngestDate | Wed Aug 27 01:30:33 EDT 2025 Thu Aug 21 17:56:31 EDT 2025 Thu Sep 04 16:56:45 EDT 2025 Fri Jul 25 23:35:54 EDT 2025 Tue Jun 17 21:39:21 EDT 2025 Tue Jun 10 20:43:46 EDT 2025 Fri Jun 27 04:40:46 EDT 2025 Thu May 22 21:19:51 EDT 2025 Mon Jul 21 05:42:41 EDT 2025 Thu Apr 24 23:10:04 EDT 2025 Tue Jul 01 03:06:12 EDT 2025 Sat Sep 06 07:29:06 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Prognostic factor Spinal metastasis Revised Tokuhashi score Overall survival |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c668t-bc3a2d8ac12bf524c586f24d45158effaed4c4079f48807fdeb312e9dac776c3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-9846-6735 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12885-018-5139-2 |
| PMID | 30545326 |
| PQID | 2158428956 |
| PQPubID | 44074 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_ebe71e3e278d4a128d18e886be8c2333 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6293585 proquest_miscellaneous_2157677386 proquest_journals_2158428956 gale_infotracmisc_A569030590 gale_infotracacademiconefile_A569030590 gale_incontextgauss_ISR_A569030590 gale_healthsolutions_A569030590 pubmed_primary_30545326 crossref_citationtrail_10_1186_s12885_018_5139_2 crossref_primary_10_1186_s12885_018_5139_2 springer_journals_10_1186_s12885_018_5139_2 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-12-13 |
| PublicationDateYYYYMMDD | 2018-12-13 |
| PublicationDate_xml | – month: 12 year: 2018 text: 2018-12-13 day: 13 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC cancer |
| PublicationTitleAbbrev | BMC Cancer |
| PublicationTitleAlternate | BMC Cancer |
| PublicationYear | 2018 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | D Rades (5139_CR22) 2006; 24 S Crnalic (5139_CR29) 2012; 37 F Tancioni (5139_CR54) 2011; 36 RH Bartels (5139_CR61) 2007; 110 5139_CR80 5139_CR83 D Rades (5139_CR31) 2013; 119 HM Tao (5139_CR75) 2004; 26 CE Tatsui (5139_CR48) 2014; 20 H Gakhar (5139_CR81) 2013; 22 M Lei (5139_CR62) 2016; 41 T Yamashita (5139_CR77) 2011; 36 D Rades (5139_CR42) 2012; 188 R Patchell (5139_CR23) 2005; 366 MD Switlyk (5139_CR74) 2015; 27 JN Sellin (5139_CR45) 2015; 23 L Bollen (5139_CR34) 2014; 16 M Lei (5139_CR18) 2015; 15 T Meng (5139_CR38) 2016; 14 M Lei (5139_CR17) 2016; 42 A Leithner (5139_CR25) 2008; 17 SJ Park (5139_CR39) 2016; 16 D Rades (5139_CR50) 2016; 36 MF Oliveira (5139_CR58) 2015; 73 JP Higgins (5139_CR13) 2003; 327 5139_CR52 5139_CR10 RJ Petteys (5139_CR49) 2016; 41 5139_CR12 5139_CR56 M Mizumoto (5139_CR71) 2008; 113 M Kataoka (5139_CR59) 2012; 66 V Pointillart (5139_CR11) 2011; 137 H Chen (5139_CR64) 2010; 35 Y Tang (5139_CR36) 2015; 97 TN Byrne (5139_CR1) 1992; 327 KY Moon (5139_CR67) 2011; 50 DG Ju (5139_CR32) 2013; 73 K Tomita (5139_CR6) 2001; 26 P Vanek (5139_CR35) 2015; 40 M Egger (5139_CR14) 1997; 315 S Kato (5139_CR51) 2016; 5 Y Tokuhashi (5139_CR3) 1990; 15 S Chong (5139_CR30) 2012; 12 D Zhang (5139_CR79) 2013; 38 5139_CR60 Y Guo (5139_CR66) 2003; 82 D Rades (5139_CR21) 2014; 34 PL Zadnik (5139_CR55) 2011; 31 S Ogihara (5139_CR72) 2006; 31 JH Park (5139_CR26) 2011; 50 BP Walcott (5139_CR53) 2011; 18 WB Jacobs (5139_CR2) 2001; 11 C Choi (5139_CR65) 2015; 9 S Helweg-Larsen (5139_CR69) 2000; 46 F Tancioni (5139_CR47) 2012; 21 YJ Chen (5139_CR37) 2015; 10 DM Drzymalski (5139_CR46) 2010; 13 RT Arrigo (5139_CR27) 2011; 68 YJ Chen (5139_CR24) 2007; 32 L Jiang (5139_CR57) 2014; 127 M Lei (5139_CR16) 2016; 25 RB North (5139_CR8) 2005; 2 BH Lee (5139_CR44) 2014; 122 SB Yang (5139_CR68) 2012; 51 5139_CR73 D Rades (5139_CR20) 2011; 81 5139_CR76 5139_CR9 D Rades (5139_CR19) 2012; 188 5139_CR78 5139_CR7 Y Tokuhashi (5139_CR4) 2005; 30 RA Huddart (5139_CR40) 1997; 44 S Duval (5139_CR15) 2000; 56 BJ Williams (5139_CR41) 2009; 10 A Sandler (5139_CR82) 2006; 355 NA Bakker (5139_CR33) 2014; 14 S Crnalic (5139_CR43) 2012; 83 N Kumar (5139_CR70) 2014; 14 D Rades (5139_CR28) 2012; 188 PJ Sioutos (5139_CR5) 1995; 76 SS Chang (5139_CR63) 2001; 13 |
| References_xml | – volume: 5 start-page: 2343 issue: 9 year: 2016 ident: 5139_CR51 publication-title: Cancer Med doi: 10.1002/cam4.823 – volume: 97 start-page: 1418 issue: 17 year: 2015 ident: 5139_CR36 publication-title: J Bone Joint Surg Am doi: 10.2106/JBJS.N.01124 – volume: 26 start-page: 298 issue: 3 year: 2001 ident: 5139_CR6 publication-title: Spine (Phila Pa 1976) doi: 10.1097/00007632-200102010-00016 – volume: 17 start-page: 1488 issue: 11 year: 2008 ident: 5139_CR25 publication-title: Eur Spine J doi: 10.1007/s00586-008-0763-1 – volume: 41 start-page: 1469 issue: 18 year: 2016 ident: 5139_CR62 publication-title: Spine (Phila Pa 1976) doi: 10.1097/BRS.0000000000001538 – volume: 2 start-page: 564 year: 2005 ident: 5139_CR8 publication-title: J Neurosurg: Spine – volume: 110 start-page: 2042 issue: 9 year: 2007 ident: 5139_CR61 publication-title: Cancer doi: 10.1002/cncr.23002 – volume: 327 start-page: 557 year: 2003 ident: 5139_CR13 publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 15 start-page: 1110 year: 1990 ident: 5139_CR3 publication-title: Spine doi: 10.1097/00007632-199011010-00005 – volume: 355 start-page: 2542 issue: 24 year: 2006 ident: 5139_CR82 publication-title: N Engl J Med doi: 10.1056/NEJMoa061884 – volume: 13 start-page: 789 issue: 6 year: 2010 ident: 5139_CR46 publication-title: J Neurosurg Spine. doi: 10.3171/2010.6.SPINE10167 – ident: 5139_CR12 – volume: 41 issue: 2 year: 2016 ident: 5139_CR49 publication-title: Neurosurg Focus doi: 10.3171/2016.5.FOCUS16145 – volume: 31 start-page: 1585 issue: 14 year: 2006 ident: 5139_CR72 publication-title: Spine (Phila Pa 1976) doi: 10.1097/01.brs.0000222146.91398.c9 – volume: 24 start-page: 3388 issue: 21 year: 2006 ident: 5139_CR22 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.05.0542 – volume: 16 start-page: 322 issue: 3 year: 2016 ident: 5139_CR39 publication-title: Spine J doi: 10.1016/j.spinee.2015.11.005 – volume: 66 start-page: 213 issue: 3 year: 2012 ident: 5139_CR59 publication-title: Acta Med Okayama – volume: 38 start-page: E1090 issue: 17 year: 2013 ident: 5139_CR79 publication-title: Spine (Phila Pa 1976) doi: 10.1097/BRS.0b013e3182983bf8 – ident: 5139_CR73 doi: 10.1016/j.ijrobp.2005.06.036 – volume: 32 start-page: E413 issue: 15 year: 2007 ident: 5139_CR24 publication-title: Spine (Phila Pa 1976) doi: 10.1097/BRS.0b013e318074d6c7 – volume: 30 start-page: 2186 year: 2005 ident: 5139_CR4 publication-title: Spine doi: 10.1097/01.brs.0000180401.06919.a5 – volume: 315 start-page: 629 year: 1997 ident: 5139_CR14 publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 16 start-page: 991 issue: 7 year: 2014 ident: 5139_CR34 publication-title: Neuro-Oncology doi: 10.1093/neuonc/not318 – ident: 5139_CR10 doi: 10.1007/s00586-012-2649-5 – volume: 51 start-page: 127 issue: 3 year: 2012 ident: 5139_CR68 publication-title: J Korean Neurosurg Soc doi: 10.3340/jkns.2012.51.3.127 – volume: 14 start-page: 2038 issue: 9 year: 2014 ident: 5139_CR33 publication-title: Spine J doi: 10.1016/j.spinee.2014.04.013 – volume: 76 start-page: 1453 year: 1995 ident: 5139_CR5 publication-title: Cancer doi: 10.1002/1097-0142(19951015)76:8<1453::AID-CNCR2820760824>3.0.CO;2-T – volume: 12 start-page: 1083 issue: 12 year: 2012 ident: 5139_CR30 publication-title: Spine J doi: 10.1016/j.spinee.2012.10.015 – volume: 25 start-page: 3971 issue: 12 year: 2016 ident: 5139_CR16 publication-title: Eur Spine J doi: 10.1007/s00586-015-4290-6 – ident: 5139_CR83 doi: 10.1158/1078-0432.CCR-09-0520 – volume: 36 start-page: 910 issue: 11 year: 2011 ident: 5139_CR77 publication-title: Spine (Phila Pa 1976) doi: 10.1097/BRS.0b013e3181e56ec1 – volume: 34 start-page: 2503 issue: 5 year: 2014 ident: 5139_CR21 publication-title: Anticancer Res – volume: 127 start-page: 4092 issue: 23 year: 2014 ident: 5139_CR57 publication-title: Chin Med J doi: 10.3760/cma.j.issn.0366-6999.20141625 – volume: 82 start-page: 665 issue: 9 year: 2003 ident: 5139_CR66 publication-title: Am J Phys Med Rehabil doi: 10.1097/01.PHM.0000083662.85497.1F – volume: 10 start-page: 414 issue: 5 year: 2009 ident: 5139_CR41 publication-title: J Neurosurg Spine. doi: 10.3171/2009.1.SPINE08509 – volume: 13 start-page: 1341 issue: 11 year: 2001 ident: 5139_CR63 publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/00042737-200111000-00013 – volume: 327 start-page: 614 year: 1992 ident: 5139_CR1 publication-title: N Engl J Med doi: 10.1056/NEJM199208273270907 – volume: 42 start-page: 728 issue: 5 year: 2016 ident: 5139_CR17 publication-title: Eur Spine J – ident: 5139_CR80 doi: 10.1097/00007632-199710010-00020 – volume: 366 start-page: 643 year: 2005 ident: 5139_CR23 publication-title: Lancet. doi: 10.1016/S0140-6736(05)66954-1 – ident: 5139_CR56 doi: 10.1245/s10434-006-9000-5 – volume: 10 start-page: 149 year: 2015 ident: 5139_CR37 publication-title: J Orthop Surg Res doi: 10.1186/s13018-015-0291-8 – volume: 68 start-page: 674 issue: 3 year: 2011 ident: 5139_CR27 publication-title: Neurosurgery doi: 10.1227/NEU.0b013e318207780c – volume: 36 start-page: E1352 issue: 20 year: 2011 ident: 5139_CR54 publication-title: Spine (Phila Pa 1976) doi: 10.1097/BRS.0b013e318207a222 – volume: 73 start-page: 330 issue: 4 year: 2015 ident: 5139_CR58 publication-title: Arq Neuropsiquiatr doi: 10.1590/0004-282X20150003 – volume: 188 start-page: 472 issue: 6 year: 2012 ident: 5139_CR28 publication-title: Strahlenther Onkol doi: 10.1007/s00066-012-0086-3 – volume: 119 start-page: 897 issue: 4 year: 2013 ident: 5139_CR31 publication-title: Cancer doi: 10.1002/cncr.27849 – volume: 83 start-page: 80 issue: 1 year: 2012 ident: 5139_CR43 publication-title: Acta Orthop doi: 10.3109/17453674.2011.590761 – volume: 18 start-page: 1336 issue: 10 year: 2011 ident: 5139_CR53 publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2011.02.020 – volume: 50 start-page: 216 issue: 3 year: 2011 ident: 5139_CR67 publication-title: J Korean Neurosurg Soc. doi: 10.3340/jkns.2011.50.3.216 – volume: 21 start-page: S146 issue: Suppl 1 year: 2012 ident: 5139_CR47 publication-title: Eur Spine J doi: 10.1007/s00586-012-2232-0 – volume: 27 start-page: 213 issue: 4 year: 2015 ident: 5139_CR74 publication-title: Clin Oncol (R Coll Radiol) doi: 10.1016/j.clon.2015.01.002 – volume: 81 start-page: e861 issue: 5 year: 2011 ident: 5139_CR20 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2010.11.056 – volume: 26 start-page: 226 issue: 4 year: 2004 ident: 5139_CR75 publication-title: Zhonghua Zhong Liu Za Zhi – volume: 14 start-page: 200 issue: 1 year: 2016 ident: 5139_CR38 publication-title: World J Surg Oncol doi: 10.1186/s12957-016-0961-y – volume: 188 start-page: 802 issue: 9 year: 2012 ident: 5139_CR42 publication-title: Strahlenther Onkol doi: 10.1007/s00066-012-0106-3 – volume: 122 start-page: 80 year: 2014 ident: 5139_CR44 publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2014.04.025 – volume: 46 start-page: 1163 issue: 5 year: 2000 ident: 5139_CR69 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(99)00333-8 – volume: 9 start-page: 94 issue: 1 year: 2015 ident: 5139_CR65 publication-title: Gut Liver doi: 10.5009/gnl14009 – volume: 44 start-page: 229 issue: 3 year: 1997 ident: 5139_CR40 publication-title: Radiother Oncol doi: 10.1016/S0167-8140(97)00112-6 – ident: 5139_CR78 doi: 10.1016/j.jotr.2013.12.004 – volume: 188 start-page: 424 issue: 5 year: 2012 ident: 5139_CR19 publication-title: Strahlenther Onkol doi: 10.1007/s00066-011-0058-z – volume: 31 start-page: 47 issue: 1 year: 2011 ident: 5139_CR55 publication-title: Clin Exp Metastasis doi: 10.1007/s10585-013-9608-3 – volume: 56 start-page: 455 year: 2000 ident: 5139_CR15 publication-title: Biometrics doi: 10.1111/j.0006-341X.2000.00455.x – volume: 40 start-page: 1824 issue: 23 year: 2015 ident: 5139_CR35 publication-title: Spine (Phila Pa 1976) – volume: 35 start-page: E1339 issue: 23 year: 2010 ident: 5139_CR64 publication-title: Spine (Phila Pa 1976) doi: 10.1097/BRS.0b013e3181e574f5 – volume: 137 start-page: 849 issue: 5 year: 2011 ident: 5139_CR11 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-010-0946-0 – ident: 5139_CR7 doi: 10.3109/17453679508995508 – volume: 50 start-page: 434 issue: 5 year: 2011 ident: 5139_CR26 publication-title: J Korean Neurosurg Soc. doi: 10.3340/jkns.2011.50.5.434 – ident: 5139_CR9 doi: 10.1002/cncr.20756 – volume: 36 start-page: 2035 issue: 4 year: 2016 ident: 5139_CR50 publication-title: Anticancer Res – volume: 14 start-page: 2946 issue: 12 year: 2014 ident: 5139_CR70 publication-title: Spine J doi: 10.1016/j.spinee.2014.06.001 – volume: 15 start-page: 853 year: 2015 ident: 5139_CR18 publication-title: BMC Cancer doi: 10.1186/s12885-015-1852-2 – volume: 73 start-page: 657 issue: 4 year: 2013 ident: 5139_CR32 publication-title: Neurosurgery doi: 10.1227/NEU.0000000000000070 – volume: 20 start-page: 108 issue: 1 year: 2014 ident: 5139_CR48 publication-title: J Neurosurg Spine doi: 10.3171/2013.9.SPINE13158 – ident: 5139_CR52 doi: 10.1007/s00586-007-0380-4 – ident: 5139_CR76 doi: 10.1007/s00066-013-0473-4 – volume: 22 start-page: 565 issue: 3 year: 2013 ident: 5139_CR81 publication-title: Eur Spine J doi: 10.1007/s00586-012-2480-z – volume: 11 start-page: e10 year: 2001 ident: 5139_CR2 publication-title: Neurosurg Focus doi: 10.3171/foc.2001.11.6.11 – volume: 37 start-page: 2168 issue: 26 year: 2012 ident: 5139_CR29 publication-title: Spine (Phila Pa 1976) doi: 10.1097/BRS.0b013e31826011bc – ident: 5139_CR60 doi: 10.1007/s00586-016-4921-6 – volume: 23 start-page: 419 issue: 4 year: 2015 ident: 5139_CR45 publication-title: J Neurosurg Spine. doi: 10.3171/2015.1.SPINE14431 – volume: 113 start-page: 2816 issue: 10 year: 2008 ident: 5139_CR71 publication-title: Cancer doi: 10.1002/cncr.23888 |
| SSID | ssj0017808 |
| Score | 2.310172 |
| SecondaryResourceType | review_article |
| Snippet | Background
Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases... Cancer patients' survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the... Background Cancer patients' survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases... Background Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases... Abstract Background Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1248 |
| SubjectTerms | Accuracy Biomedical and Life Sciences Biomedicine Bones Breast cancer Cancer metastasis Cancer patients Cancer Research Care and treatment Health aspects Health Promotion and Disease Prevention Hepatocellular carcinoma Liver cancer Lung cancer Lung carcinoma Medical prognosis Medicine/Public Health Meta-analysis Metastases Metastasis Non-small cell lung carcinoma Oncology Overall survival Patients Prognosis Prognostic factor Quality of life Radiation therapy Research Article Revised Tokuhashi score Small cell lung carcinoma Spinal cord Spinal metastasis Spine Studies Supportive therapy Surgery Surgical Oncology survivorship and psychosocial oncology Systematic review Thyroid cancer Vertebrae |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDI_QDogL4pvCgICQkEDRmo8mKbeBmAbSQwiGtFuUJimbgHZa3-MP4S_GbvPe1iHgwq1qnDaNHceunZ8JeQpmfYiWK5ZaFZmqlWZ1Gzlr2wa2Y8W953jAefFe739W7w6rw3OlvjAnbIIHniZuB15ieJJJGBuVB20auU3W6ibZIKQccT7Lulw7Uzl-YGxpcwyTW70zQD-LSWqWVWDyMDHbhUaw_t9V8rk96WK-5IWg6bgX7V0jV7MRSXenwV8nl1J3g1xe5DD5TfLzw2mPCXTQTKeEDdq3NJfWoccdqKQfKcIFxSTfAS4P-q-rI6yrRAfEtaQTwDMFi5Zm5NWB4i9bOpxgGS36PS092JVDGl5ST8_goOl0FIb6LtIF0DCfQU9ukYO9Nwev91kuvsCC1nbJmiC9iNYHLpq2EipUVrdCRQUGkIWh-xRVAG-wblEFmDaCV85FqqMPxuggb5Otru_SXUK9lKlsKhNEJZXU3NaB80ZJCyw0TZIFKde8cCEDk2N9jG9udFCsdhP7HLDPIfucKMjzTZeTCZXjb8SvkMEbQgTUHm-AmLksZu5fYlaQRygebjqdulELbrfSNerMuizIk5ECQTU6zNr54lfD4N5--jgjepaJ2h6-Mfh8CAJmCnG4ZpTbM0pY9WHevJZTl7XO4MB8s-BOgstbkMebZuyJmXRd6lcjjdEGS70W5M4k1puZgSerCuz5gpiZwM-mbt7SHR-NmORaYEC9KsiL9dI4G9YfOXPvf3DmPrkicGFzwbjcJlvL01V6AIbisnk46oRfoVZmCA priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection (Proquest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fi9QwEA56gvgi_r7qqVEEQQm3SdMk9UVO8TiFFdEV7i2kSXp3qO263fUP8S92ps3u2hPvrTTTkmQyky_J5BtCngGs98FwyWItA5OlVKysA2d1XcF0LLlzHC84Tz-qo6_yw3FxnDbcuhRWufaJvaMOrcc98n2YmgxAZYDzr-c_GWaNwtPVlELjMrnCAYlg6gZ9vFlwcW0mJp1kcqP2O_DFBkPVDCsA-DAxmot6yv5_HfNfM9P5qMlzR6f9jHR4g1xPUJIeDLq_SS7F5ha5Ok2H5bfJ70-LFsPooJgOYRu0rWlKsEPPGnBMv2KAB4qhvh08ztpvq1PMrkQ7ZLekA80zBVxLE_9qR3HjlnZzTKZFf8SlA3TZxe4VdXRLCk2HCzHUNYFOQYa5RH1yh8wO383eHrGUgoF5pcySVT53IhjnuajqQkhfGFULGSTAIANVdzFID2vCskZHoOsAa3MuYhmc11r5_C7Zadom7hLq8jxOqkJ7UeQyV9yUnvNK5qaKRlcxz8hkrQvrEz05Zsn4bvtlilF2UJ8F9VlUnxUZebH5ZD5wc1wk_AYVvBFEWu3-Rbs4sclKLYxozWMehTZBOvhF4CYao6COXuQ5VPIxDg873FHdOAd7UKgSPWc5ycjTXgKpNRqM3Tlxq66z7798Hgk9T0J1C230Ll2FgJ5CNq6R5N5IEmzfj4vX49Qm39PZraVk5MmmGL_EeLomtqteRiuNCV8zcm8Y1puegT_LAlB9RvRowI-6blzSnJ32zORK4LF6kZGXa9PYVuu_mrl_cSMekGsCTZYLxvM9srNcrOJDAILL6lFv7X8ATpxdaA priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ra9UwFA8yQfwi8103NYogKMWbR5PUb_PimMIV0SvsW0iTdBtqO9Z7_UP8iz2nze3W-QC_heakpDmPnPSc_A4hz8Ct98EwmcdahlyWUuVlHVhe1xVsx5I5x_CC8-KDOvgi3x8WhwksGu_CXIzfM6NedWA_DaaXmbwAZyUHa3sVGjMU5rmajwEDbWYmBS3_OGyy7fTo_L_b4Aub0OUEyUtR0n7z2d8mN5LXSPcGNt8kV2Jzi1xbpLj4bfLz41mLGXPQTYcMDdrWNNXSoScN2KAfMUCDYlZvB81l-3V9jIWUaIdAlnRAdKbgwtIEtdpR_EdLu1Osm0W_x5UDR7KL3Wvq6Dn-Mx3uvlDXBLoAmtwllJM7ZLn_djk_yFO1hdwrZVZ55YXjwTjPeFUXXPrCqJrLIMHjMTB1F4P0cPwra9R5XQc4hjMey-C81sqLu2SraZt4n1AnRJxVhfa8EFIoZkrPWCWFqaLRVRQZmW14YX1CIseCGN9sfyIxyg7ss8A-i-yzPCMvxiGnAwzHv4jfIINHQkTQ7h-AYNmkkBaEV7MoItcmSAevCMxEYxTM0XMhYJKPUTzscB11tAN2r1AlGslylpGnPQWiaDSYpnPk1l1n333-NCF6nojqFr7Ru3TrAVYKgbcmlLsTSlBzP-3eyKlNZqaz4K8ZOD_CGTcjT8ZuHImpc01s1z2NVhpru2bk3iDW48rAm2UBDnxG9ETgJ0s37WlOjnsQcsUxgl5k5OVGNc6n9VfOPPgv6h1ynaMGM54zsUu2Vmfr-BBcwFX1qFf-X7KxVeM priority: 102 providerName: Springer Nature |
| Title | Prognostic effect of factors involved in revised Tokuhashi score system for patients with spinal metastases: a systematic review and Meta-analysis |
| URI | https://link.springer.com/article/10.1186/s12885-018-5139-2 https://www.ncbi.nlm.nih.gov/pubmed/30545326 https://www.proquest.com/docview/2158428956 https://www.proquest.com/docview/2157677386 https://pubmed.ncbi.nlm.nih.gov/PMC6293585 https://doaj.org/article/ebe71e3e278d4a128d18e886be8c2333 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1tb9MwELbGJiG-IN4JjGIQEhIoUDuO7SAh1FabBlKnqXTSxBfLcZxtYiSjaRH8DX4xd0nakjGQ-BKl8cVyfS8-587PEfIM3HqXaSZCn4ssFImQYZJnLMzzFJZjwaxleMB5vC_3DsWHo_hogyzLW7UTWF26tcN6Uoezs1ffv_54Bwr_tlZ4LV9XYGM1pqDpMAaHJgSLvFWHizCTT6yDCkrXBeoY2GMMKqg2yHlpF51lqkbz_9Nm_7ZoXUyovBBVrRer3Rvkeutl0kEjFjfJhi9ukavjNo5-m_w8mJWYYQfNtMnooGVO29o79LQAm_XNZ3BDMQu4gttp-XlxgoWXaIXAl7RBgKbg8tIWmrWi-E2XVudYZ4t-8XMLjmflqzfU0jVeNG3OylBbZHQMNKFtUVHukOnuznS0F7bVGUInpZ6HqYssz7R1jKd5zIWLtcy5yAR4SBqGbn0mHMxykqONUHkG23bGfZJZp5R00V2yWZSFv0-ojSLfT2PleByJSDKdOMZSEenUa5X6KCD9JS-Ma5HLsYDGmal3MFqahn0G2GeQfYYH5MXqlfMGtuNfxENk8IoQEbfrB-Xs2LQKbEDYFfOR50pnwkIXGdNeawljdDyKYJCPUTxMc3x1ZTfMIJYJGtWkH5CnNQWibhSY1nNsF1Vl3n-cdIiet0R5Cf_R2faUBMwUAnV1KLc7lGAWXLd5KadmqVUG_DsN-03YEwfkyaoZ38RUu8KXi5pGSYW1YANyrxHr1cxAzyIGhz8gqiPwnanrthSnJzVoueQYcY8D8nKpGuth_ZUzD_6HjQ_JNY4KzHjIom2yOZ8t_CPwGOdpj1xRR6pHtoY7-wcT-DWSo1799aVXWwi4Toaf4HrIB78AFLBsHg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3_T9UwEG8QEvUX43enKNVoTDQLr13XdSbEgEJAeITgM-G3pms7IOqG7D2N_4b_j_-bd1vfw2HkN35b1lvT9dq7a-_uc4Q8B7PeOsVE7EvhYpELGeelY3FZFqCOBTOGYYLzcFdufhIfDtKDOfJ7mguDYZVTmdgKaldbvCNfBtWkwFQGc_7tybcYq0ahd3VaQsOE0gpupYUYC4kd2_7nDzjCNStb74HfLzjfWB-924xDlYHYSqnGcWETw50ylvGiTLmwqZIlF06Aple-LI13wsKxJy9xrWelg-Mn4z53xmaZtAl0e4UsCLw_mScLa-u7e_szN0amBiq4UpmSyw0oA4WxcipOwfKKeU8ZtjUD_tUMf6nG82Gb53y3rUrcuEluBFuWrnaL7xaZ89VtcnUYvPV3yK-90xrj-KCZdnEjtC5pqPBDjyuQjN-9gweKscYNPI7qz5MjLO9EG4TXpB3ONAXDmgYA2IbizTFtTrCaF_3qxwbM28Y3b6ihZ6jUtMvIoaZydAg0sQnYK3fJ6DK4c4_MV3XlHxBqksQPijSzPE1EIpnKLWOFSFThVVb4JCKDKS-0DfjoWKbji27PSUrqjn0a2KeRfZpH5NXsk5MOHOQi4jVk8IwQcb3bF_XpoQ5iQsOWyphPPM-UEwa6cEx5pSSM0fIkgUEu4fLQXZLsTDrp1VTmKLrzQUSetRSI7VFh8NChmTSN3vq43yN6GYjKGv7RmpCLATOFcGA9ysUeJQgf22-erlMdhF-jz7ZqRJ7OmvFLDOirfD1paTKZYcXZiNzvlvVsZqBnkcKxIiJZb8H3pq7fUh0ftdDokqNfP43I6-nWOBvWfznz8OKfWCLXNkfDHb2ztbv9iFznuH0Zj1mySObHpxP_GKzScfEk7H1K9CVLmz_O96Hg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rb9MwELfQkCa-IN4EBjMICQkUrX7EcfhWHtUGdJqgk_bNcmxnm4Ckalr-EP5i7hK3I-Mh8S2qz5HrO5_vcne_I-QZmPXOaybTUEmfykKqtKg8S6uqhOtYMmsZFjhPD9X-sXx_kp3EPqftOtt9HZLsaxoQpale7s191R9xrfZa0Koak850moEJk4IOvirhqsacrmM-3oQRcj3SMZT5x2mDy6jD7P9dM_9yNV1Om7wUO-2upMkNcj3aknTcM_8muRLqW2R7GqPlt8mPo0WDeXQwTPu8DdpUNHbYoec1aKbvwcMDxVzfFh5nzZfVGbZXoi3CW9Ie55mCYUsjAGtL8cstbefYTYt-C0sL5mUb2lfU0gtUaNpXxFBbezoFmtRG7JM7ZDZ5N3uzn8YeDKlTSi_T0gnLvbaO8bLKuHSZVhWXXoIdpGHpNnjpwCksKtQEeeXBOWc8FN66PFdO3CVbdVOH-4RaIcKozHLHMyGFYrpwjJVS6DLovAwiIaM1L4yL-OTYJuOr6fwUrUzPPgPsM8g-wxPyYjNl3oNz_Iv4NTJ4Q4i42t0PzeLUxGNqQKRzFkTgufbSwis800FrBWt0XAhY5C6Kh-mLVDfawYwzVaDqLEYJedpRILZGjck7p3bVtubg86cB0fNIVDXwH52NtRCwUwjHNaDcGVDC4XfD4bWcmqh8WgNWnAavEjzfhDzZDONMTKirQ7PqaHKVY8fXhNzrxXqzM_BmmYFZn5B8IPCDrRuO1OdnHTS54hhXzxLycn00Lpb1V848-C_qXbJ99HZiPh4cfnhIrnE8zIynTOyQreViFR6BjbgsH3d64CcHjWE4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+effect+of+factors+involved+in+revised+Tokuhashi+score+system+for+patients+with+spinal+metastases%3A+a+systematic+review+and+Meta-analysis&rft.jtitle=BMC+cancer&rft.au=Yang%2C+Xiong-gang&rft.au=Lun%2C+Deng-xing&rft.au=Hu%2C+Yong-cheng&rft.au=Liu%2C+Yong-heng&rft.date=2018-12-13&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1186%2Fs12885-018-5139-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12885_018_5139_2 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |